COMMUNIQUÉS West-GlobeNewswire

Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
11/08/2025
Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Artelo [...]
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
11/08/2025
SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported [...]
PharmaTher Announces FDA Approval of Ketamine (KETARx™)
11/08/2025
TORONTO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of [...]
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
11/08/2025
WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a [...]
TOMI Environmental Solutions Secures Order from ARES Distribution
11/08/2025
FREDERICK, Md., Aug. 11, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced that it has [...]
Managed Healthcare Executive® announces 2025 PBMI Innovators Award winners
11/08/2025
Celebrating six visionaries driving meaningful innovation in pharmacy benefit management CRANBURY, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Managed Healthcare Executive® is proud to announce the winners of the 2025 PBMI [...]
Rising Cyber Threats to Brazil’s Health Sector Highlighted in New Health-ISAC Report
11/08/2025
Attacks on Brazil’s health system are rising, and limited intelligence sharing is contributing to put patient data and critical infrastructure at risk. ORLANDO, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Health-ISAC, a non [...]
Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
11/08/2025
Tinlarebant granted Breakthrough Therapy Designation for Stargardt disease (STGD1) by the U.S. Food and Drug Administration (FDA) DRAGON trial completion expected by Q4 2025 (including a three-month follow-up period) [...]
Zymeworks Strengthens Board of Directors with Appointments of Greg Ciongoli and Robert E. Landry
11/08/2025
VANCOUVER, British Columbia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the [...]
Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events
11/08/2025
STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to [...]
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
11/08/2025
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s disease 1 Ianalumab [...]
Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds
11/08/2025
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August 11, 2025 Idorsia Ltd (SIX: IDIA) announces the interim results of the repurchase offer for its outstanding CHF 204 * million convertible bonds [...]
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025
11/08/2025
Nyxoah Annonce ses Résultats Préliminaires pour le Deuxième Trimestre 2025 Mont-Saint-Guibert, Belgique – 11 août 2025, 7h00 CET / 01h00 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société »), [...]
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
11/08/2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium – August 11, 2025, 7:00am CET / 1:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a [...]
AVITA Medical to Host Investor Webinar Briefing
11/08/2025
VALENCIA, Calif., Aug. 10, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective [...]
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges
10/08/2025
Total Company Revenue increased 8.4% to a quarterly record of $498.2 million in the second quarter of 2025 from $459.7 million in the second quarter of 2024; Revenue from the Digital Health reportable segment (inclusive [...]
IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma
10/08/2025
NEW YORK, Aug. 10, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company, today announced the company will hold a conference call and webcast on Monday, August 11, 2025, at 8:30 [...]
Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand
09/08/2025
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, Folqs First-Day Colostrum Powder . This positions the company within the growing colostrum [...]
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System
09/08/2025
Covering both mosquito-borne diseases and emerging respiratory pathogens, Anbio continues to advance point-of-care diagnostics for timely outbreak detection worldwide. FRANKFURT, Germany, Aug. 08, 2025 (GLOBE NEWSWIRE [...]

Pages